GlaxoSmithKline PLC's ticker is and the CUSIP is G3910J112.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $207,000 | -12.7% | 5,499 | -5.3% | 0.06% | -17.8% |
| Q2 2020 | $237,000 | +9.2% | 5,805 | +1.6% | 0.07% | -5.2% |
| Q1 2020 | $217,000 | -13.2% | 5,715 | +7.2% | 0.08% | +4.1% |
| Q4 2019 | $250,000 | +10.1% | 5,330 | 0.0% | 0.07% | +5.7% |
| Q3 2019 | $227,000 | -34.6% | 5,330 | -38.5% | 0.07% | -32.7% |
| Q2 2019 | $347,000 | – | 8,670 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cullen Capital Management, LLC | 498,400 | $10,693,000 | 0.29% |
| ArchPoint Investors | 11,370 | $260,000 | 0.10% |
| MYCIO WEALTH PARTNERS, LLC | 5,782 | $124,000 | 0.03% |
| SCHAFER CULLEN CAPITAL MANAGEMENT INC | 83,079 | $1,782,000 | 0.02% |